HSIC vs NVST
HSIC: Henry Schein is a leading global distributor of dental and medical supplies, equipment, and practice management software for office-based healthcare practitioners. NVST: Envista is a diversified global dental products company providing a comprehensive range of consumables, equipment, and digital workflow solutions to dental professionals.
Side-by-side fundamentals
| Metric | HSIC | NVST | Edge |
|---|---|---|---|
| Price as of 2026-10-08 close | $84.63 | $22.72 | |
| Market cap | $9.4B | $3.6B | |
| P/E as of 2026-10-08 | 24.66 | 39.46 | HSIC lower |
| Net margin FY2025, SEC XBRL | +3.0% | +1.7% | HSIC higher |
| Gross margin FY2025, SEC XBRL | +31.1% | +54.7% | NVST higher |
| Operating margin FY2025, SEC XBRL | +5.0% | +7.9% | NVST higher |
| ROE FY2025, SEC XBRL | +10.2% | +1.5% | HSIC higher |
| ROA FY2025, SEC XBRL | +3.5% | +0.8% | HSIC higher |
| Debt / equity as of 2026-09-03 | 1.10 | 0.47 | NVST lower |
| Revenue growth (YoY) as of 2026-09-03 | +6.5% | +11.9% | NVST higher |
| Revenue CAGR (3y) SEC XBRL | +1.4% | +1.9% | NVST higher |
| Dividend streak (yrs) SEC XBRL | 0 | 0 | Tie |
| Beta as of 2026-09-03 | 0.56 | 1.20 | |
| 1-year return as of 2026-10-08 close | +30.7% | +10.4% | HSIC higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.